Canadian Science Publishing (CSP), an independent not-for-profit publisher with a strong reputation for excellence in scientific journal publishing, has acquired Journal of Psychiatry and Neuroscience (JPN) from CMA Impact Inc., a wholly owned subsidiary of the Canadian Medical Association, effective September 2, 2025.
JPN publishes papers at the intersection of psychiatry and neuroscience that advance our understanding of the neural mechanisms involved in the etiology and treatment of psychiatric disorders. The journal becomes the 23rd title in the CSP portfolio, which includes some of Canada’s longest-standing and most respected peer-reviewed journals, covering engineering, life, natural, and physical sciences.
“We’re pleased to welcome JPN to our growing suite of journals,” says Josephine E. Sciortino, Editorial Director, Life & Agricultural Sciences at CSP. “JPN is a unique addition to our portfolio and marks an exciting step forward as we expand and connect with a new community of researchers.”
JPN’s Editorial Board remains unchanged and will maintain full control over the journal’s content and editorial decisions.
“With their community-focused approach and a strong commitment to publishing quality science, we know JPN is in good hands,” says Holly Bodger, Publisher at CMA Impact Inc. “We look forward to seeing the journal continue to grow and succeed in its new home with Canadian Science Publishing.”
CSP looks forward to supporting the continued impact of JPN and will provide further updates as preparations progress for its transition in September.
To learn more about Canadian Science Publishing and its portfolio of journals please visit www.cdnsciencepub.com. For more information about the Canadian Medical Association, please visit www.cma.ca.
